Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mario Romano
Institution:
University of Campania "Luigi Vanvitelli"
Observed institutions:
University of Campania "Luigi Vanvitelli",
Policlinico Umberto I,
Azienda Ospedaliera Sant'Andrea,
Ospedale Sandro Pertini
OpenAlex ID:
A5103517569
Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3
2005
·
Alessandra Mangia
, Rosanna Santoro
, et al.
·
New England Journal of Medicine
·
886
PDF
Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial
2007
·
Alessandra Mangia
, Nicola Minerva
, et al.
·
Hepatology
·
254
PDF
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR
2010
·
Alexander J. Thompson
, Rosanna Santoro
, et al.
·
Hepatology
·
81
PDF
Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection #
2008
·
Alessandra Mangia
, Nicola Minerva
, et al.
·
Hepatology
·
70
Endogenous levels of mRNA for IFNs and IFN‐related genes in hepatic biopsies of chronic HCV‐infected and non‐alcoholic steatohepatitis patients
2003
·
Isabella Abbate
, Mario Romano
, et al.
·
Journal of Medical Virology
·
37
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
2012
·
and for the CLEO Group
, Adriano M Pellicelli
, et al.
·
BMC Gastroenterology
·
29
PDF
Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3
2010
·
Alessandra Mangia
, Franco Bandiera
, et al.
·
Journal of Hepatology
·
27
Short versus standard treatment with pegylated interferon alfa-2A plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the cleo trial
2010
·
Fabrizio Mecenate
, Adriano M Pellicelli
, et al.
·
BMC Gastroenterology
·
26
PDF
Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon α‐2a and ribavirin: a multicentric study
2009
·
Claudio Puoti
, Adriano M. Pellicelli
, et al.
·
Liver International
·
19
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency
2014
·
Floriano Rosina
, Maria Elena Tosti
, et al.
·
Digestive and Liver Disease
·
15
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience
2016
·
Antonio Ascione
, CLEO Study Group
, et al.
·
World Journal of Hepatology
·
10
Which is the real efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in HCV infected patients with advanced fibrosis?
2012
·
Adriano M. Pellicelli
, Mario Romano
, et al.
·
Journal of Hepatology
PDF
IFN system activation in liver from naive HCV chronic patients
2002
·
Isabella Abbate
, Mario Romano
, et al.
·
Journal of Hepatology
Show more works
View as search
Works count:
13
Citation count:
1,454
H-index:
10
I10-index:
11
Year
Topic
Type